I think we're better positioned now as a company than we have ever been in the history of Advanced Energy,” CEO Steve Kelley said during the company’s earnings call on Tuesday.

Novocure (NASDAQ: NVCR) announced today that the U.S. Food and Drug Administration (FDA) approved Optune Pax ® for the treatment of adult patients with locally advanced pancreatic cancer concomitant ...

Level2, a fully visual, no-code platform for trading strategy creation and automation, today announced a partnership with Public, the long-term investing platform. Integrated directly into Public, ...